Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Share-based Compensation (2016 - 2025)

Arrowhead Pharmaceuticals' Share-based Compensation history spans 16 years, with the latest figure at $19.4 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 27.37% year-over-year to $19.4 million; the TTM value through Dec 2025 reached $67.5 million, down 2.81%, while the annual FY2025 figure was $63.4 million, 14.33% down from the prior year.
  • Share-based Compensation reached $19.4 million in Q4 2025 per ARWR's latest filing, up from $19.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $34.6 million in Q3 2021 to a low of $3.3 million in Q1 2021.
  • Average Share-based Compensation over 5 years is $20.2 million, with a median of $19.4 million recorded in 2022.
  • Peak YoY movement for Share-based Compensation: skyrocketed 754.55% in 2022, then plummeted 40.26% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $24.5 million in 2021, then fell by 20.87% to $19.4 million in 2022, then rose by 1.57% to $19.7 million in 2023, then fell by 22.77% to $15.2 million in 2024, then rose by 27.37% to $19.4 million in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Share-based Compensation are $19.4 million (Q4 2025), $19.1 million (Q3 2025), and $13.0 million (Q2 2025).